1. Home
  2. LMFA vs VRAX Comparison

LMFA vs VRAX Comparison

Compare LMFA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMFA
  • VRAX
  • Stock Information
  • Founded
  • LMFA 2008
  • VRAX 2013
  • Country
  • LMFA United States
  • VRAX United Kingdom
  • Employees
  • LMFA N/A
  • VRAX N/A
  • Industry
  • LMFA Finance: Consumer Services
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • LMFA Finance
  • VRAX Health Care
  • Exchange
  • LMFA Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • LMFA 7.0M
  • VRAX 5.9M
  • IPO Year
  • LMFA 2015
  • VRAX 2022
  • Fundamental
  • Price
  • LMFA $1.43
  • VRAX $1.09
  • Analyst Decision
  • LMFA Hold
  • VRAX Strong Buy
  • Analyst Count
  • LMFA 1
  • VRAX 1
  • Target Price
  • LMFA N/A
  • VRAX $3.00
  • AVG Volume (30 Days)
  • LMFA 36.4K
  • VRAX 300.7K
  • Earning Date
  • LMFA 05-15-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • LMFA N/A
  • VRAX N/A
  • EPS Growth
  • LMFA N/A
  • VRAX N/A
  • EPS
  • LMFA N/A
  • VRAX N/A
  • Revenue
  • LMFA $10,555,948.00
  • VRAX $84,872.00
  • Revenue This Year
  • LMFA $0.98
  • VRAX $5,169.18
  • Revenue Next Year
  • LMFA $4.31
  • VRAX $66.97
  • P/E Ratio
  • LMFA N/A
  • VRAX N/A
  • Revenue Growth
  • LMFA N/A
  • VRAX 7.03
  • 52 Week Low
  • LMFA $1.02
  • VRAX $0.60
  • 52 Week High
  • LMFA $6.11
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • LMFA 57.42
  • VRAX 48.47
  • Support Level
  • LMFA $1.11
  • VRAX $0.91
  • Resistance Level
  • LMFA $1.50
  • VRAX $1.09
  • Average True Range (ATR)
  • LMFA 0.13
  • VRAX 0.11
  • MACD
  • LMFA 0.04
  • VRAX 0.03
  • Stochastic Oscillator
  • LMFA 85.36
  • VRAX 51.92

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: